Third Rock Ventures News
Most Popular Third Rock Ventures Story
VC launches $378M fund
Boston-based Third Rock Ventures has launched a fund with $378 million of committed capital that will be used to invest in life sciences companies at the early stages of formation. Third Rock said it... Read more...
Latest Headlines
- September 14, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
